The present invention is directed to compounds of formula (I), wherein R1 is a ring and n is a number from 1 to 8. The invention also relates to use of the compounds in therapy as metabotropic glutamate receptor modulators, particularly in neurological and psychiatric disorders.
本发明涉及式(I)的化合物,其中R1是一个环,n是1到8之间的数字。该发明还涉及将这些化合物用于治疗作为代谢型谷
氨酸受体调节剂,特别是在神经系统和精神疾病中的用途。